Search NLS News

Thanks to a donation of SEK 35 million from financier and philanthropist Rune Andersson, Karolinska Institutet’s research group leader Andrea Carmine Belin will very soon be setting up the world’s first research centre specializing exclusively in cluster headaches. “The emergency prophylactic treatments available have been developed for other diseases and aren’t optimal,” says docent and […]

Mendus has presented survival data based on the completed active study period and long-term follow-up to date from the ADVANCE II clinical trial at the American Society of Hematology Annual Meeting. ADVANCE II is a Phase 2 monotherapy trial evaluating DCP-001 as a maintenance therapy in acute myeloid leukemia (AML) for patients brought into complete […]

IRLAB Therapeutics has announced that the final patient has completed the treatment period and follow-up visit in the Phase IIb study of mesdopetam in levodopa-induced dyskinesia in people with Parkinson’s disease (PD-LIDs). The top-line results are expected to be reported in mid-January 2023, states the company in a press release. An oral dopamine D3 antagonist […]

The two companies have entered into an agreement to create a global biosolutions partner through a statutory merger. The proposed combination of Novozymes and Chr. Hansen will create a group with a broad biological toolbox and a diversified portfolio across markets, the companies state. Together, the combined group will be equipped to stand stronger in addressing […]

The Health Capital Helsinki area offers a mixture of global healthcare corporations, an active startup community, and academic strengths. Health Capital Helsinki (HCH) was initiated in 2015 by the City of Helsinki and the University of Helsinki. The original idea was to ensure the success of startups originating from research innovations, describes Juha Paakkola, Director […]

SynAct Pharma has entered into a conditional agreement on acquisition of TXP Pharma, a Swiss-incorporated biotech company researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The purchase price consists of a fixed purchase price of SEK 136 million and a potential additional purchase price of SEK 55 million, where the […]

Jenni Nordborg will lead the work of advancing the industry’s positions globally, starting during the Swedish chairmanship within the EU. During the past five years Nordborg has led the Swedish government’s efforts of developing and strengthening Sweden as a life science nation as the government’s Coordinator for Life Sciences. She has played a central role […]

This following the signing of agreements between Genomic Medicine Sweden’s (GMS) fourteen partnering regions and universities. Thus far, this is being done within research projects pending an update in legislation. “The ability to share health data, such as genomics data, is a prerequisite for precision medicine. Not only to be able to provide the right […]

Barbro Ehnbom and her SALSS team have invited dignitaries in science, life science and healthcare to participate in a manifestation for peace and solidarity with Ukraine in Stockholm, December 11-12. The former big pharma executive and Wall Street analyst founded the Swedish-American Life Science Summit (SALSS) 20 years ago and the conference has since then […]

The launch of Pixelgen Technologies follows the close of an approximate 6 million USD seed round, led by Navigare Ventures. The founding will support the commercialization next year of the company’s Molecular Pixelation technology for spatial analyses of cell surface proteins in 3D. “We are pioneering a completely new approach to spatial proteomics with Molecular […]